Opinion Review
Copyright ©The Author(s) 2022.
World J Hepatol. Aug 27, 2022; 14(8): 1530-1540
Published online Aug 27, 2022. doi: 10.4254/wjh.v14.i8.1530
Table 2 Studies of hepatic venous pressure gradient changes with phosphodiesterase-5 inhibitors
HVPG change
Intervention
Ref.
No significant change in HVPGTadalafil 10 mg Jagdish et al[1], 2021, Hept International
N = 10, in seven patients, HVPG decreased and in three it increased but the decrease was not significant Sildenafil 50 mg Clemmesen et al[43], 2008, World J Gastroenterology
Lowers portal pressure in the acute setting by about 20% 75-100 mg of the phosphodiesterase-5-inhibitor udenafilKreisel et al[44], 2015, Dig Liver Dis
Decreased HVPG in 4/5 patientsVardenafil 10 mg Deibert et al[45], 2006, Aliment Pharmacol Ther
No effect on HVPG Sildenafil Tandon et al[46], 2010, Clin Gastroenterol Hepatol
HVPG decrease from 10 mmHg to 7 mmHg (case report)Sildenafil 20 mg bd Bremer et al[47], 2007, J Med Case Rep
HVPG decreased by 13%, and portal flow increased by 28% (case report)VardenafilDeibert et al[48], 2018, World J Gastroenterology